CD19-CART(Relma-cel) for Moderate to Severe Active Systemic Lupus Erythematosus

Clinical trial NCT05765006 · UNKNOWN

Trial details

NCT number: NCT05765006
Sponsor: Shanghai Ming Ju Biotechnology Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus

Start date: 2023-02-24
Primary completion: 2024-12-30
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.